Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: In vitro and in vivo evaluations

References

• Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. (2005). In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohydr Polym, 61, 39–51.
   Web of Science ®Google Scholar
• Basit AW. (2005). Advances in colonic drug delivery. Drugs, 65, 1991–2007.
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337–342.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov, 5, 493–506.
   PubMed Web of Science ®Google Scholar
• Cardoso SM, Coimbra MA, Lopes da Silva JA. (2003). Temperature dependence of the formation and melting of pectin-Ca 2+ networks: A rheological study. Food Hydrocolloids, 17, 801–807.
   Web of Science ®Google Scholar
• Chambin O, Dupuis G, Champion D, Voilley A, Pourcelot Y. (2006). Colon-specific drug delivery: Influence of solution reticulation properties upon pectin beads performance. Int J Pharm, 321, 86–93.
   PubMed Web of Science ®Google Scholar
• Chang C, Wang ZC, Quan CY, Cheng H, Cheng SX, Zhang XZ, Zhuo RX. (2007). Fabrication of a novel pH-sensitive glutaraldehyde cross-linked pectin nanogel for drug delivery. J Biomater Sci Polym Ed, 18, 1591–1599.
   PubMed Web of Science ®Google Scholar
• Das S, Lin HS, Ho PC, Ng KY. (2008). The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res, 25, 2593–2600.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY. (2010). Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier. Int J Pharm, 385, 20–28.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY. (2010). Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. J Pharm Sci, 99, 840–860.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY, Ho PC. (2010). Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol. AAPS PharmSciTech, 11, 729–742.
   PubMed Web of Science ®Google Scholar
• Dupuis G, Chambin O, Génelot C, Champion D, Pourcelot Y. (2006). Colonic drug delivery: influence of cross-linking agent on pectin beads properties and role of the shell capsule type. Drug Dev Ind Pharm, 32, 847–855.
   PubMed Web of Science ®Google Scholar
• El-Gibaly I. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm, 232, 199–211.
   PubMed Web of Science ®Google Scholar
• Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 57, 247–265.
   PubMed Web of Science ®Google Scholar
• Gescher AJ, Steward WP. (2003). Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev, 12, 953–957.
   PubMed Web of Science ®Google Scholar
• Gilsenan PM, Richardson RK, Morris ER. (2000). Thermally reversible acid-induced gelation of low-methoxy pectin. Carbohydr Polym 41:339–349.
   Web of Science ®Google Scholar
• Grant GT, Morris ER, Rees DA. (1973). Biological interactions between polysaccharides and divalent cations: The egg box model. FEBS Letters, 32, 195–198.
   Web of Science ®Google Scholar
• Kaldas MI, Walle UK, Walle T. (2003). Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol, 55, 307–312.
   PubMed Web of Science ®Google Scholar
• Liu L, Fishman ML, Kost J, Hicks KB. (2003). Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials, 24, 3333–3343.
   PubMed Web of Science ®Google Scholar
• Lootens D, Capel F, Durand D, Nicolai T, Boulenguer P, Langendorff V. (2003). Influence of pH, Ca concentration, temperature and amidation on the gelation of low methoxyl pectin. Food Hydrocolloids, 17, 237–244.
   Web of Science ®Google Scholar
• Maestrelli F, Cirri M, Corti G, Mennini N, Mura P. (2008). Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm, 69, 508–518.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, Mennini N, Mura P. (2008). Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci, 34, 1–11.
   PubMed Web of Science ®Google Scholar
• Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jäger W. (2006). Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res, 23, 2107–2115.
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. (2002). Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther, 302, 369–373.
   PubMed Web of Science ®Google Scholar
• Martín AR, Villegas I, La Casa C, de la Lastra CA. (2004). Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol, 67, 1399–1410.
   PubMed Web of Science ®Google Scholar
• Martín AR, Villegas I, Sánchez-Hidalgo M, de la Lastra CA. (2006). The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol, 147, 873–885.
   PubMed Web of Science ®Google Scholar
• Murata Y, Miyashita M, Kofuji K, Miyamoto E, Kawashima S. (2004). Drug release properties of a gel bead prepared with pectin and hydrolysate. J Control Release, 95, 61–66.
   PubMed Web of Science ®Google Scholar
• Schneider Y, Duranton B, Gossé F, Schleiffer R, Seiler N, Raul F. (2001). Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer, 39, 102–107.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P. (1999). Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci, 8, 221–227.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Nunthanid J. (1999). Calcium pectinate gel beads for controlled release drug delivery: II. Effect of formulation and processing variables on drug release. J Microencapsul, 16, 303–313.
   PubMed Web of Science ®Google Scholar
• Tessitore L, Davit A, Sarotto I, Caderni G. (2000). Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis, 21, 1619–1622.
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos, 32, 1377–1382.
   PubMed Web of Science ®Google Scholar